Disorder |
Affected Gene(s) |
Phenotype assessment |
Reference(s) |
a1-antitrypsin deficiency |
SERPINA1 |
Aggregation of misfolded alpha1-antitrypsin in the endoplasmic reticulum |
[182] |
Adrenoleukodystrophy, X-linked |
Unknown |
iPSC-oligodendrocytes exhibit very long chain fatty acid level |
[183] |
Alzheimer’s disease, familial |
PSEN1, PSEN2
APP |
iPSC-neurons have increased amyloid β42 secretion, phosphorylated-Tau and active glycogen synthase kinase-3b as well as accumulation of large Rab5+ early endosomes |
[103,154] |
Alzheimer’s disease, sporadic |
Unknown |
Increased levels of amyloid-b, phosphorylated-Tau and active glycogen synthase kinase-3b as well as accumulation of large Rab5+ early endosomes |
[103] |
Amyotrophic lateral sclerosis, familial |
TARDBP or VAPB |
TARDBP iPSC neurons have elevated levels of soluble and detergent-resistant TDP-43 protein, decreased survival in longitudinal studies, and increased vulnerability to antagonism of the PI3K pathway; VAPB fibroblasts, iPSCs and hiPSC neurons have reduced levels of VAPB |
[184,185] |
Catecholaminergic polymorphic ventricular tachycardia type 1 |
CASQ2or RYR2 |
iPSC cardiomyocytes are arrhythmogenic, have delayed afterdepolarizations, after-contractions, and exhibit higher amplitudes and longer durations of spontaneous Ca2+-release |
[150,186-188] |
Chronic granulomatous disease, X-linked |
CYBB or NCF1 |
iPSC neutrophils or iPSC-macrophages lack ROS production |
[189,190] |
Chronic infantile neurological cutaneous and articular syndrome |
NLRP3 |
iPSC marcophages show abnormal IL1b secretion |
[191] |
Chronic myelogenous leukemia |
BCR-ABL |
iPSC mature but not immature hematopoietic cells are sensitive to imatinib |
[192] |
Dilated cardiomyopathy |
LMNA or Tnnt2 |
iPSC-fibroblasts have nuclear membrane abnormalities, increased senescence and susceptibility to apoptosis; iPSC-cardiomyocytes show altered regulation of Ca2+, decreased contractility, abnormal distribution of sarcomeric α-ACTININ, and cellular stress upon stimulation with a β-adrenergic agonist |
[193,194] |
Down syndrome |
Trisomy 21 |
iPSC teratoma microvessel density is significantly reduced (reference 195; iPSC-neurons processed the transmembrane APP protein, resulting in secretion of the pathogenic peptide fragment amyloid-β42, a feature of Alzheimer’s disease (reference 196) |
[195,196] |
Dyskeratosis congenita |
DKC1, TERC or TCAB1 |
iPSC show progressive telomere shortening and loss of self-renewal |
[197,198] |
Familial Dysautonomia |
IKBKAP |
Decreased expression of genes involved in neurogenesis and neuronal differentiation; defects in neural crest migration |
[151] |
Familial Hypercholesterolemia |
LDLR |
hiPSC-derived hepatocytes have an impaired ability to incorporate LDL, increased secretion of lipidated ApoB-100 |
[182,199] |
Fragile X syndrome |
FMR1 |
iPSC show aberrant neuronal differentiation with loss of expression of FMRP |
[200] |
Gaucher’s disease type III |
GBA |
iPSC-neurons have compromised lysosomal protein degradation, accumulation of α-SYNUCLEIN and neurotoxicity through aggregation-dependent mechanisms |
[201] |
Glycogen storage disease type 1A |
G6PC |
iPSC-hepatocytes hyperaccumulate glycogen and lipid, and have excessive production of lactic acid |
[182] |
Huntington’s disease |
HTT |
iPSC-neural stem/progenitor cells show enhanced caspase activity upon growth factor deprivation; iPSC asctrocytes show cytoplasmic vacuolation; iPSC but not iPSC neurons have significantly increased lysosomal activity |
[115,202-205] |
Hurler syndrome (Mucopolysaccharidosis type I) |
IDUA |
iPSC have an imbalance between production and clearance of unprocessed GAG and show lysosomal storage defects |
[206] |
Hutchinson-Gilford progeria |
LMNA |
iPSC mesenchymal stem cells, vascular smooth muscle cells and fibroblasts display progerin accumulation, increased DNA damage, and nuclear abnormalities; iPSC- vascular smooth muscle cells also show premature senescence, blebbing and increased apoptosis |
[193,207,208] |
Juvenile Diabetes * |
LDLR |
iPSC hepatocytes show features of hypercholesteremia |
[199] |
LEOPARD syndrome |
PTPN11 |
iPSC cardiomyocytes reveal features of cardiac hypertrophy (increased size, increased sarcomere organization and increased nuclear localization of NFATC4) |
[140] |
Long QT 3 and Brugada overlap syndrome |
SCN5A1798insD/+ |
iPSC cardiomyocytes show reduced upstroke velocity and longer action potential duration |
[209] |
Long QT syndromes |
KCNQ1 (LQT1); KCNH2 (LQT2), SCN5A (LQT3), CACNA1C (LQT8/Timothy syndrome) |
iPSC cardiomyocytes have a prolonged action potential duration reminiscent of delayed repolarization, early afterdepolarization (LQT3), and irregular contraction, excess Ca2+ influx, irregular electrical activity and abnormal calcium transients (LQT8/Timothy syndrome) |
[210-215] |
Machado-Joseph disease |
ATXN3 |
iPSC neurons show formation of SDS-insoluble aggregates after Ca2+-dependent proteolysis of ATXN3 |
[216] |
Marfan syndrome |
FBN1 |
iPSC show inhibition of osteogenic differentiation, enhanced TGFb-signaling, and chondrogenic differentiation without TGF b1 media supplementation |
[217] |
Mucopolysaccharidosis type IIIB |
NAGLU |
iPSCs and differentiated neurons derived from patients show defects in storage vesicles and Golgi apparatus |
[218] |
Parkinson’s disease, familial |
LRRK2, SNCA or PINK1 |
iPSC dopaminergic neurons show impaired mitochondrial function; iPSC dopaminergic neurons have increased expression of key oxidative stress response genes and α-synuclein protein, and increased sensitivity to oxidative-stress; accumulation of autophagic vacuoles |
[156,219-223] |
Polycythaemia vera |
JAK2 |
iPSC hematopoietic cells have enhanced erythropoiesis |
[224] |
Pompe disease |
GAA |
iPSC cardiomyocytes show high levels of glycogen and multiple ultrastructural aberrances |
[225] |
Prader-Willi syndrome |
Translocation of the paternally expressed chromosome 15q11-q13 region to chromosome 4 |
iPSCs express reduced levels of the disease-associated small nucleolar RNA HBII-85/SNORD116 |
[226] |
Retinitis pigmentosa |
RP1, RP9, PRPh2 or RHO |
iPSC rod cells numbers are decreased, express markers for oxidation or endoplasmic reticulum stress, and show different responses to vitamin E |
[227] |
Rett Syndrome |
MECP2 |
iPSC neurons have decreased synapse number, reduced number of spines, a reduction in soma size, altered calcium signaling, and elevated LINE1 retrotransposon mobility |
[153,228-231] |
Schizophrenia |
Unknown |
iPSC neurons showed diminished neuronal connectivity in conjunction with decreased neurite number, PSD95-protein levels and glutamate receptor expression; iPSC neurons have an increase in extra-mitochondrial oxygen consumption as well as elevated levels of reactive oxygen species |
[104,105] |
Sickle cell disease |
HBB |
Marginally increased HBB mRNA levels |
[117] |
Spinal muscular atrophy |
SMN1 |
iPSC motor neurons have a reduced size and decrease in numbers over time; show an abnormality in neurite outgrowth |
[152,232] |
Timothy syndrome |
CACAN1C |
iPSC cardiomyocytes have irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients
iPSC cortical neurons have defects in Ca2+-signaling and activity-dependent gene expression, as well as abnormalities in cortical neuron differentiation |
[212,233] |
Werner syndrome, atypical |
LMNA |
iPSC fibroblasts show nuclear membrane abnormalities, increased senescence and susceptibility to apoptosis |
[193] |
Wilson’s disease |
ATP7B |
iPSC hepatocytes mislocalize mutated ATP7B and have defective copper transport |
[234] |